1
|
Gkentzi D, Mhliordos K, Karatza A, Sinopidis X, Dimopoulou D, Eleftheriou E, Tsolia M, Mavridi A, Miliara E, Papaevangelou V, Vergadi E, Galanakis E, Dimitriou G, Fouzas S. The Psychological Impact of COVID-19 Admission on Families: Results from a Nationwide Sample in Greece. Children (Basel) 2022; 9:children9121933. [PMID: 36553376 PMCID: PMC9777457 DOI: 10.3390/children9121933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Revised: 11/29/2022] [Accepted: 12/05/2022] [Indexed: 12/14/2022]
Abstract
The aim of the present study was to assess the psychological impact of hospitalization during the COVID-19 pandemic on parents and their offspring. We performed a nationwide cross-sectional study in Greece based on an Internet questionnaire survey. A convenience sample of parents whose offspring had been hospitalized due to COVID-19 (including multisystem inflammatory syndrome in children, MIS-C), diagnosed with COVID-19 but not hospitalized, and hospitalized for another reason during the pandemic were enrolled. Parental stress was assessed using the Perceived Stress Scale (PSS) and the Revised Impact of Event Scale (IES-R) tools, and childhood mental wellbeing with the Children’s Revised Impact of Event 13 (CRIES-13) scale. Out of 214 received responses, stress levels were significantly higher in parents whose children had been admitted for COVID-19 or MIS-C versus those not admitted or admitted for other reasons (p < 0.001, for PSS/IES-R). Parental and childhood stress levels were correlated. In the multivariable linear regression analysis, children’s hospitalization because of COVID-19 or MIS-C, younger parental age, the existence of comorbidities, and another family member’s hospitalization because of COVID-19 were independent factors for higher stress. In light of the above, stricter hospital admission criteria for COVID-19 could be implemented, and psychological support for eventually admitted families may be beneficial.
Collapse
Affiliation(s)
- Despoina Gkentzi
- Department of Pediatrics, Medical School, University of Patras, 26504 Rio Patras, Greece
| | - Konstantinos Mhliordos
- Department of Pediatrics, Medical School, University of Patras, 26504 Rio Patras, Greece
| | - Ageliki Karatza
- Department of Pediatrics, Medical School, University of Patras, 26504 Rio Patras, Greece
| | - Xenophon Sinopidis
- Department of Pediatrics, Medical School, University of Patras, 26504 Rio Patras, Greece
| | - Dimitra Dimopoulou
- Department of Pediatrics, Second Department of Paediatrics, School of Medicine, P. and A. Kyriakou Children’s Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
| | - Eirini Eleftheriou
- Department of Pediatrics, Second Department of Paediatrics, School of Medicine, P. and A. Kyriakou Children’s Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
| | - Maria Tsolia
- Department of Pediatrics, Second Department of Paediatrics, School of Medicine, P. and A. Kyriakou Children’s Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
| | - Artemis Mavridi
- Department of Pediatrics, Third Department of Paediatrics, School of Medicine, Attikon General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
| | - Eugenia Miliara
- Department of Pediatrics, Third Department of Paediatrics, School of Medicine, Attikon General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
| | - Vassiliki Papaevangelou
- Department of Pediatrics, Third Department of Paediatrics, School of Medicine, Attikon General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece
| | - Eleni Vergadi
- Department of Paediatrics, School of Medicine, University of Crete, 71500 Heraklion, Greece
| | - Emmanouil Galanakis
- Department of Paediatrics, School of Medicine, University of Crete, 71500 Heraklion, Greece
| | - Gabriel Dimitriou
- Department of Pediatrics, Medical School, University of Patras, 26504 Rio Patras, Greece
- Correspondence:
| | - Sotirios Fouzas
- Department of Pediatrics, Medical School, University of Patras, 26504 Rio Patras, Greece
| |
Collapse
|
2
|
Abstract
This study aimed to systematically analyze all cases of infective endocarditis (IE) by Klebsiella species in the literature. A systematic review of PubMed, Scopus and Cochrane library (through 27th January 2021) for studies providing epidemiological, clinical, microbiological as well as treatment data and outcomes of IE by Klebsiella species was performed. In this review, a total of 66 studies were included, providing data for 67 patients. A prosthetic valve was present in 16.4%, while the most common causative pathogen was K. pneumoniae followed by K. oxytoca. The aortic valve was the most commonly infected intracardiac site, followed by the mitral valve. The diagnosis was based on transthoracic echocardiography in 46.2%, while the diagnosis was set at autopsy in 9.2% of included patients. Blood cultures were positive in 93.8%. Fever and sepsis were the most frequent clinical presentations, followed by embolic phenomena, paravalvular abscess, and heart failure. Cephalosporins, aminoglycosides, and carbapenems were the most frequently used antimicrobials. Surgical treatment along with antimicrobials was performed in 37.3% of included patients. Clinical cure was noted in 80.3%, while the overall mortality was 19.4%. Infection at the aortic valve was independently associated with mortality by IE. This systematic review gives a comprehensive description of IE by Klebsiella and provides information on epidemiology, clinical manifestations, therapeutic strategies and their outcomes.
Collapse
Affiliation(s)
- Petros Ioannou
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Greece
| | - Eugenia Miliara
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Greece
| | - Stella Baliou
- National Hellenic Research Foundation, Athens, Greece
| | - Diamantis P Kofteridis
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Greece
| |
Collapse
|
3
|
Ioannou P, Vougiouklakis G, Baliou S, Miliara E, Kofteridis DP. Infective Endocarditis by Yersinia Species: A Systematic Review. Trop Med Infect Dis 2021; 6:tropicalmed6010019. [PMID: 33540800 PMCID: PMC7931003 DOI: 10.3390/tropicalmed6010019] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Revised: 01/27/2021] [Accepted: 01/27/2021] [Indexed: 01/04/2023] Open
Abstract
Yersinia spp. are non-spore-forming Gram-negative bacilli. They comprise only three species known to cause disease in humans, namely Y. pestis, Y. enterocolitica and Y. pseudotuberculosis. Since infective endocarditis (IE) is rarely caused by Yersinia, the management of these infections can be problematic due to the lack of experience. The purpose of this study was to systematically review all published cases of IE by Yersinia species in the literature. A systematic review of PubMed, Scopus and Cochrane Library (through 1 November 2020) for studies providing epidemiological, clinical and microbiological information as well as data on treatment and outcomes of IE caused by Yersinia species was performed. A total of 12 studies, containing data of 12 patients, were included. A prosthetic valve was present in 17% of patients. The mitral valve was the most commonly infected site, followed by the aortic valve. Fever, sepsis and embolic phenomena were common clinical signs, followed by heart failure. Aminoglycosides, cephalosporins and quinolones were the most commonly used antimicrobials. Clinical cure was noted in 83%, while overall mortality was 17%. This systematic review describes IE by Yersinia and provides information on patients’ epidemiology, clinical signs and the related therapeutic strategies and outcomes.
Collapse
Affiliation(s)
- Petros Ioannou
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, 71110 Crete, Greece; (G.V.); (E.M.); (D.P.K.)
- Correspondence: ; Tel.: +30-2810392424
| | - Georgios Vougiouklakis
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, 71110 Crete, Greece; (G.V.); (E.M.); (D.P.K.)
| | - Stella Baliou
- National Hellenic Research Foundation, 11635 Athens, Greece;
| | - Eugenia Miliara
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, 71110 Crete, Greece; (G.V.); (E.M.); (D.P.K.)
| | - Diamantis P. Kofteridis
- Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, 71110 Crete, Greece; (G.V.); (E.M.); (D.P.K.)
| |
Collapse
|